• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7-取代的 7-(杂芳基)-7-去氮杂腺苷核苷对分枝杆菌和人腺苷激酶的抑制作用的结构基础。

Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides.

机构信息

Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic , Flemingovo nam. 2, 16610 Prague 6, Czech Republic.

出版信息

J Med Chem. 2014 Oct 23;57(20):8268-79. doi: 10.1021/jm500497v. Epub 2014 Oct 8.

DOI:10.1021/jm500497v
PMID:25259627
Abstract

Adenosine kinase (ADK) from Mycobacterium tuberculosis (Mtb) was selected as a target for design of antimycobacterial nucleosides. Screening of 7-(het)aryl-7-deazaadenine ribonucleosides with Mtb and human (h) ADKs and testing with wild-type and drug-resistant Mtb strains identified specific inhibitors of Mtb ADK with micromolar antimycobacterial activity and low cytotoxicity. X-ray structures of complexes of Mtb and hADKs with 7-ethynyl-7-deazaadenosine showed differences in inhibitor interactions in the adenosine binding sites. 1D (1)H STD NMR experiments revealed that these inhibitors are readily accommodated into the ATP and adenosine binding sites of Mtb ADK, whereas they bind preferentially into the adenosine site of hADK. Occupation of the Mtb ADK ATP site with inhibitors and formation of catalytically less competent semiopen conformation of MtbADK after inhibitor binding in the adenosine site explain the lack of phosphorylation of 7-substituted-7-deazaadenosines. Semiempirical quantum mechanical analysis confirmed different affinity of nucleosides for the Mtb ADK adenosine and ATP sites.

摘要

结核分枝杆菌(Mycobacterium tuberculosis,Mtb)中的腺苷激酶(Adenosine kinase,ADK)被选为设计抗分枝杆菌核苷的靶标。用 Mtb 和人(h)ADK 对 7-(杂)芳基-7-脱氮腺苷核苷进行筛选,并对野生型和耐药性 Mtb 菌株进行测试,鉴定出对 Mtb ADK 具有微摩尔抗分枝杆菌活性和低细胞毒性的特异性抑制剂。Mtb 和 hADK 与 7-乙炔基-7-脱氮腺苷复合物的 X 射线结构显示,在腺苷结合位点,抑制剂的相互作用存在差异。1D(1)H STD NMR 实验表明,这些抑制剂很容易被容纳到 Mtb ADK 的 ATP 和腺苷结合位点中,而它们优先结合到 hADK 的腺苷位点。抑制剂占据 Mtb ADK 的 ATP 结合位点,以及抑制剂结合到腺苷位点后形成催化能力较弱的半开放构象,解释了 7-取代-7-脱氮腺苷的磷酸化缺失。半经验量子力学分析证实了核苷对 Mtb ADK 腺苷和 ATP 结合位点的不同亲和力。

相似文献

1
Structural basis for inhibition of mycobacterial and human adenosine kinase by 7-substituted 7-(Het)aryl-7-deazaadenine ribonucleosides.7-取代的 7-(杂芳基)-7-去氮杂腺苷核苷对分枝杆菌和人腺苷激酶的抑制作用的结构基础。
J Med Chem. 2014 Oct 23;57(20):8268-79. doi: 10.1021/jm500497v. Epub 2014 Oct 8.
2
2-Substituted 6-(Het)aryl-7-deazapurine Ribonucleosides: Synthesis, Inhibition of Adenosine Kinases, and Antimycobacterial Activity.2-取代 6-(杂芳基)-7-脱氮嘌呤核苷:合成、腺苷激酶抑制和抗分枝杆菌活性。
ChemMedChem. 2015 Jun;10(6):1079-93. doi: 10.1002/cmdc.201500081. Epub 2015 Apr 16.
3
High resolution crystal structures of Mycobacterium tuberculosis adenosine kinase: insights into the mechanism and specificity of this novel prokaryotic enzyme.结核分枝杆菌腺苷激酶的高分辨率晶体结构:对这种新型原核酶的作用机制和特异性的深入了解。
J Biol Chem. 2007 Sep 14;282(37):27334-27342. doi: 10.1074/jbc.M703290200. Epub 2007 Jun 26.
4
Structure-activity relationship for nucleoside analogs as inhibitors or substrates of adenosine kinase from Mycobacterium tuberculosis. I. Modifications to the adenine moiety.结核分枝杆菌腺苷激酶抑制剂或底物核苷类似物的构效关系。I. 腺嘌呤部分的修饰。
Biochem Pharmacol. 2006 Jun 14;71(12):1671-82. doi: 10.1016/j.bcp.2006.03.006. Epub 2006 Mar 10.
5
CycloSal-phosphate pronucleotides of cytostatic 6-(Het)aryl-7-deazapurine ribonucleosides: Synthesis, cytostatic activity, and inhibition of adenosine kinases.细胞生长抑制剂 6-(杂芳基)-7-脱氮嘌呤核苷的环磷酰基磷酸核苷:合成、细胞生长抑制活性和对腺嘌呤激酶的抑制作用。
ChemMedChem. 2010 Aug 2;5(8):1386-96. doi: 10.1002/cmdc.201000192.
6
Synthesis, cytostatic, antimicrobial, and anti-HCV activity of 6-substituted 7-(het)aryl-7-deazapurine ribonucleosides.6-取代的 7-(杂)芳基-7-去氮嘌呤核苷的合成、细胞毒活性、抗微生物活性和抗 HCV 活性。
J Med Chem. 2014 Feb 13;57(3):1097-110. doi: 10.1021/jm4018948. Epub 2014 Jan 16.
7
South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.作为人腺苷激酶抑制剂的南(S)-和北(N)-甲基碳硼烷-7-脱氮腺苷类似物
J Med Chem. 2016 Jul 28;59(14):6860-77. doi: 10.1021/acs.jmedchem.6b00689. Epub 2016 Jul 13.
8
Synthesis and cytostatic and antiviral activities of 2'-deoxy-2',2'-difluororibo- and 2'-deoxy-2'-fluororibonucleosides derived from 7-(Het)aryl-7-deazaadenines.7-(杂芳基)-7-脱氮嘌呤核苷类化合物的合成及细胞毒和抗病毒活性。
ChemMedChem. 2013 May;8(5):832-46. doi: 10.1002/cmdc.201300047. Epub 2013 Apr 4.
9
Increasing the structural coverage of tuberculosis drug targets.增加结核病药物靶点的结构覆盖范围。
Tuberculosis (Edinb). 2015 Mar;95(2):142-8. doi: 10.1016/j.tube.2014.12.003. Epub 2014 Dec 19.
10
Repurposing the chemical scaffold of the anti-arthritic drug Lobenzarit to target tryptophan biosynthesis in Mycobacterium tuberculosis.重新利用抗关节炎药物洛苯达唑的化学支架来靶向结核分枝杆菌中的色氨酸生物合成。
Chembiochem. 2014 Apr 14;15(6):852-64. doi: 10.1002/cbic.201300628. Epub 2014 Mar 12.

引用本文的文献

1
Discovery of Hepatotoxic Equivalent Markers and Mechanism of Thunb. by Metabolomics Coupled with Molecular Docking.基于代谢组学结合分子对接技术发现并探讨了雷公藤致肝毒性的等效标志物及其作用机制。
Molecules. 2022 Dec 21;28(1):25. doi: 10.3390/molecules28010025.
2
Design, Synthesis, and Biochemical and Biological Evaluation of Novel 7-Deazapurine Cyclic Dinucleotide Analogues as STING Receptor Agonists.新型 7-脱氮嘌呤环二核苷酸类似物作为 STING 受体激动剂的设计、合成及生化和生物学评价。
J Med Chem. 2022 Oct 27;65(20):14082-14103. doi: 10.1021/acs.jmedchem.2c01305. Epub 2022 Oct 6.
3
Synthesis of Sugar and Nucleoside Analogs and Evaluation of Their Anticancer and Analgesic Potentials.
糖和核苷类似物的合成及其抗癌和镇痛潜力的评估。
Molecules. 2022 May 29;27(11):3499. doi: 10.3390/molecules27113499.
4
Total Synthesis of Mycalisine B.麦角新碱 B 的全合成。
Mar Drugs. 2019 Apr 14;17(4):226. doi: 10.3390/md17040226.
5
Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase.基于结构的 6-取代腺苷类似物的药物设计作为结核分枝杆菌腺苷激酶的有效抑制剂。
J Med Chem. 2019 May 9;62(9):4483-4499. doi: 10.1021/acs.jmedchem.9b00020. Epub 2019 Apr 19.
6
Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.吡咯并[2,3-d]嘧啶(7-脱氮嘌呤)作为抗肿瘤和抗病毒核苷设计中的优势骨架。
Med Res Rev. 2017 Nov;37(6):1429-1460. doi: 10.1002/med.21465. Epub 2017 Aug 23.
7
Synthesis of 8-(1,2,3-triazol-1-yl)-7-deazapurine nucleosides by azide-alkyne click reactions and direct C-H bond functionalization.通过叠氮化物-炔烃点击反应和直接C-H键官能化合成8-(1,2,3-三唑-1-基)-7-脱氮嘌呤核苷。
Tetrahedron Lett. 2016 Sep 28;57(39):4364-4367. doi: 10.1016/j.tetlet.2016.08.053. Epub 2016 Aug 19.
8
South (S)- and North (N)-Methanocarba-7-Deazaadenosine Analogues as Inhibitors of Human Adenosine Kinase.作为人腺苷激酶抑制剂的南(S)-和北(N)-甲基碳硼烷-7-脱氮腺苷类似物
J Med Chem. 2016 Jul 28;59(14):6860-77. doi: 10.1021/acs.jmedchem.6b00689. Epub 2016 Jul 13.